Literature DB >> 32057490

Efficacy of BPPV diagnosis and treatment system for benign paroxysmal positional vertigo.

Yue Lou1, Miao Cai1, Liangguo Xu1, Yanwen Wang1, Liying Zhuang1, Xiaoli Liu2.   

Abstract

OBJECTIVES: To evaluate the efficacy of automatic benign paroxysmal positional vertigo (BPPV) diagnosis and treatment system for BPPV compared with the manual repositioning group.
METHODS: Two hundred thirty patients diagnosed as idiopathic BPPV who were admitted from August 2018 to July 2019 in Zhejiang Hospital were included. Among them, 150 patients of posterior semicircular canal BPPV(pc-BPPV), 53 patients of horizontal semicircular canal BPPV(hc-BPPV), and 27 patients of horizontal semicircular canal calculus (hc-BPPV-cu) were randomly treated with BPPV diagnosis and treatment system(the experimental group) or manual repositioning (the control group). Resolution of vertigo and nystagmus on the Dix-Hallpike and Roll test on day 3,day 7,day 14 and day 28 follow-up after first treatment was the main outcome measure to assess the efficacy of treatment.
RESULTS: At 3-day and 7-day follow-up after treatment with BPPV diagnosis and treatment system, 79%, 91%had complete resolution of vertigo and nystagmus, the effective rate in the experimental group were significantly higher than those in the control group, the differences were statistically significant(P < .05). On day 14, the effective rate in the experimental group (96%) was slightly higher than that in the control group(91%), but there was no significant difference between the two groups. And at 28-day after the first treatment, the effective rate was 100% in the experimental group and the control group. The repositioning efficiency of pc-BPPV (the first, second, third treatment), hc-BPPV (the first, second, third treatment), hc-BPPV-cu(the first, second treatment) in the experimental group were higher than the control group, and the secondary reposition of pc-BPPV in the experimental group was significantly higher than the control group(96%vs.84%; P < .05). While for the hc-BPPV-cu patients, the effective rate of the third treatment in the experimental group was slightly lower than that of the control group, but the differences were not statistically significant.
CONCLUSIONS: BPPV diagnosis and treatment system is effective for the treatment of BPPV, with a better effective rate than those treated with manual maneuver, and is safe and easy to perform on patients.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BPPV diagnosis and treatment system; Benign paroxysmal positional vertigo; Dix-Hallpike test; Roll test

Year:  2020        PMID: 32057490     DOI: 10.1016/j.amjoto.2020.102412

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  5 in total

1.  Square wave manoeuvre for apogeotropic variant of horizontal canal benign paroxysmal positional vertigo in neck restricted patients.

Authors:  Dario A Yacovino; Estefania Zanotti; Karen Roman; Timothy C Hain
Journal:  J Otol       Date:  2020-11-05

2.  Craniocerebral Magnetic Resonance Imaging Features of Benign Paroxysmal Positional Vertigo under Artificial Intelligence Algorithm and the Correlation with Cerebrovascular Disease.

Authors:  Hailong Xue; Yanli Jing; Yingge Chen; Cong Xi; Na Bian; Yujuan Li
Journal:  Contrast Media Mol Imaging       Date:  2022-04-26       Impact factor: 3.009

3.  Curing Benign Paroxysmal Positional Vertigo in Patients With Brain Tumor: Case Series and Literature Review.

Authors:  Khalid Bashir; Mohammed T Bashir; Amr Elmoheen
Journal:  Cureus       Date:  2021-03-13

4.  Betahistine alleviates benign paroxysmal positional vertigo (BPPV) through inducing production of multiple CTRP family members and activating the ERK1/2-AKT/PPARy pathway.

Authors:  Jing Hui; Qi Lei; Zhi Ji; Dingjing Zi
Journal:  Biol Res       Date:  2022-04-04       Impact factor: 5.612

5.  The horizontal and vertical components of nystagmus evoked by the supine roll test in horizontal semicircular canal canalolithiasis.

Authors:  Xueqing Zhang; Qiaomei Deng; Qiang Liu; Chao Wen; Wei Wang; Taisheng Chen
Journal:  Front Neurosci       Date:  2022-08-24       Impact factor: 5.152

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.